Treating keloids: etanercept demonstrates therapeutic effect.(Clinical Dermatology) [ILLUSTRATION OMITTED] National report--A small study has shown for the first time that intralesional etanercept may provide an effective treatment for keloids, one of the authors says.Because there is currently no consistently effective...
UCB: European submission for rheumatoid arthritis treatment UCB's new biologic is awaiting European approval after being launched in the US for Crohn's disease.UCB's certolizumab is marketed under the brand name Cimzia.The submission for rheumatoid arthritis treatment, if accepted, will make it...
BeaconEquity.com issues TraderNotes on MSFT, AMGN, LINE, JNPR, ALTR, LINTA, PALM, AAPL Todays TraderNotes include: Microsoft Corporation (Nasdaq: MSFT), Amgen Inc.(Nasdaq: AMGN), Linn Energy LLC (Nasdaq: LINE), Juniper Networks Inc.
(Nasdaq: JNPR), Altera Corporation (Nasdaq: ALTR), Liberty Media Interactive (Nasdaq:...
BeaconEquity.com issues TraderNotes on MSFT, AMGN, LINE, JNPR, ALTR, LINTA, PALM, AAPL -- Todays TraderNotes include: Microsoft Corporation (Nasdaq: MSFT), Amgen Inc.(Nasdaq: AMGN), Linn Energy LLC (Nasdaq: LINE), Juniper Networks Inc.
(Nasdaq: JNPR), Altera Corporation (Nasdaq: ALTR), Liberty Media Interactive (Nasdaq:...
The Top 60: AbelsonTaylor AbelsonTaylor president and CEO Dale Taylor seems slyly elated with the fact that his agency's geographic location, hundreds of miles from the advertising epicenter of Madison Avenue, also serves as one of several secret weapons in his...
The Top 60: Euro RSCG Life Chelsea Euro RSCG Life Chelsea got new leadership this year.President Bernie Coccia joined the company in April from AgencyRx, where he had been managing partner, director of client services, while CEO and managing partner Ed Stapor took on new...
Wyeth, Tekeda launch Enbrel for RA patients Wyeth K.K.(Wyeth) and Takeda Pharmaceutical Company Limited (Takeda) announced the launch of 'Enbrel 25mg Syringe 0.5mL for S.C.
injection,' a new formulation of Enbrel (etanercept) for the treatment of rheumatoid arthritis ...
VLST Hires Paul Carter, Antibody Drug Expert, as New Chief Scientist Biotech, Antibodies, Life Sciences Luke Timmerman 7/2/08 VLST has landed a big scientific fish.The Seattle biotech startup has hired Paul Carter, a top scientist at Bothell, WA-based Seattle Genetics, as its new chief scientific officer....
Arthritis - CEL-SCI Announces Discovery of Novel Compound for the Treatment of Rheumatoid Arthritis CEL-SCI Corporation (AMEX:CVM) announced the discovery of a novel for the treatment of.This peptide, called CEL-2000, was tested in a well established of rheumatoid and was compared to Enbrel(R), a leading treatment for people with...
Wyeth and Takeda introduce new formulation of arthritis drug Enbrel 25mg Syringe 0.5mL for SC Injection is a new formulation of the existing Enbrel 25mg for SC Injection, with the drug pre-filled into the syringe.According to the company, the launch of Enbrel 25mg Syringe 0.5mL...
Health Winners & Losers: Myriad Genetics Pharma stocks outpaced the broader indices at the start of the July-Fourth week, amid a handful of regulatory news and prescription data.One stock on the decline, however, was Myriad GeneticsMYGN, which said Monday that a late-stage study...
Wyeth and Takeda introduce new formulation of arthritis drug Enbrel 25mg Syringe 0.5mL for SC Injection is a new formulation of the existing Enbrel 25mg for SC Injection, with the drug pre-filled into the syringe.According to the company, the launch of Enbrel 25mg Syringe 0.5mL...
Health Winners & Losers: Myriad Genetics Pharma stocks outpaced the broader indices at the start of the July-Fourth week, amid a handful of regulatory news and prescription data.One stock on the decline, however, was Myriad GeneticsMYGN, which said Monday that a late-stage study...
20 Compounds That Defined Biotech As we know all too well, the course of a drug candidates clinical development is almost never smooth, and can often be pitted with unanticipated obstacles.Yet, despite this, many drugs manage to not only receive the FDAs blessing, but...
Examine the Monoclonal Antibodies Report: 2008 Update Examine the Monoclonal Antibodies Report: 2008 Update - Detailed analysis of the monoclonal antibody segment, encompassing market dynamics, key therapy areas, technology and target types through to 2013, evaluating the strategies companies...
Examine the Monoclonal Antibodies Report: 2008 Update The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2013 and assessing trends by product, company, therapy area, technology and target type.It also provides...
Competitor Analysis of the Psoriasis Industry and the Development of Novel Treatments - Research and Markets (http://www.researchandmarkets.com/research/7af21e/competitor_analysi) has announced the addition of the 'Competitor Analysis: Psoriasis' report to their offering.The Competitive Intelligence Report Psoriasis R&...
Amgen/Wyeth receive OK from FDA for Enbrel The USA's respective biotechnology and drug majors Amgen and Wyeth's Enbrel (etanercept) has been recommended for approval in the treatment of pediatric psoriasis by an advisory panel to the Food and Drug Administration, despite...
FDA committee recommends expansion of Enbrel age group _ FDA committee recommends expansion of Enbrel age group.
Enbrel Gets Advisory Committee Nod for Pediatric Psoriasis While the FDAs Dermatologic and Ophthalmic Drugs Advisory Committee voted 85 for approval of Amgens TNF inhibitor Enbrel to treat pediatric psoriasis, severa Enbrel Gets Advisory Committee Nod for Pediatric Psoriasis.
FDA Panel OKs Enbrel for Psoriasis in Children -- The biologic drug Enbrel has gotten the green light from an FDA advisory committee to treat moderate to severe plaque psoriasis in children and teens who have tried other psoriasis treatments.The FDA's dermatologic and ophthalmic...
IMS: Global biotech sales up 12.5% in 2007 The biotech drug market grew by 12.5% to more than $75 billion in 2007, according to an IMS Health report.In 2006 the biotech market grew by 18.2%, to roughly $65 billion.
Profits last year were driven in large part by 22 biotech...
FDA Panel Favors Approval For Amgens Enbrel To Treat Kids With Severe Skin Disease (FinancialWire) A panel of dermatology experts for the Food and Drug Administration said Amgen Inc.'s (NASDAQ: AMGN) drug Enbrel should be approved to treat children with a serious skin disease.Earlier this month, the FDA said that...
FDA Panel Endorses Amgen's Enbrel for Psoriasis in Children PM SILVER SPRING, Md.- An expert advisory panel told the FDA Wednesday that it should approve Amgen Inc.'s Enbrel (etanercept) to treat moderate to severe plaque psoriasis in pediatric patients as young as 4 years.
The FDA's...
FDA Panel Endorses Amgen's Enbrel for Psoriasis in Children PM SILVER SPRING, Md.- An expert advisory panel told the FDA Wednesday that it should approve Amgen Inc.'s Enbrel (etanercept) to treat moderate to severe plaque psoriasis in pediatric patients as young as 4 years.
The FDA's...
